22-21388393-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001128635.2(RIMBP3B):c.4535G>A(p.Gly1512Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1512R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001128635.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000213 AC: 3AN: 140836Hom.: 0 Cov.: 15
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000426 AC: 54AN: 1268458Hom.: 0 Cov.: 20 AF XY: 0.0000427 AC XY: 27AN XY: 632346
GnomAD4 genome AF: 0.0000213 AC: 3AN: 140932Hom.: 0 Cov.: 15 AF XY: 0.0000147 AC XY: 1AN XY: 67926
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4535G>A (p.G1512E) alteration is located in exon 1 (coding exon 1) of the RIMBP3B gene. This alteration results from a G to A substitution at nucleotide position 4535, causing the glycine (G) at amino acid position 1512 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at